Japan Lifeline : Summary Report of Consolidated Financial Results for the Three Months Ended June 30, 2017 (18KB)

Summary Report of Consolidated Financial Results for the Three Months Ended June 30, 2017 [Japan GAAP]

July 28, 2017

Company name: Japan Lifeline Co., Ltd.

Code No.: 7575

Listed Stock Exchange: Tokyo Stock Exchange, 1st Section URL: http://www.jll.co.jp/

Representative: Keisuke Suzuki, President and CEO

Contact person: Shogo Takahashi, Executive Vice President Corporate Administration Department TEL: [phone]

Scheduled date for filing the Quarterly Securities Report: August 10, 2017 Dividend payable date: -

Supplementary material to the quarterly financial statements: None Presentation on quarterly results: None

（Notes: Amounts are rounded down to million yen）

1. Consolidated Results for the Three Months Ended June 30, 2017 (from April 1, 2017 to June 30, 2017)

2. Consolidated operating results (Notes: % represent year-on-year changes)

   Net sales		Operating income		Ordinary income		Net income
   Three months ended June 30, 2017	Millions of	yen %	Millions of	yen %	Millions of	yen %	Millions of	yen %
   	10,228	14.9	2,620	50.2	2,626	53.6	1,834	53.5
   Three months ended June 30, 2016	8,905	32.0	1,744	169.6	1,710	173.8	1,194	22.0

   (Note) Comprehensive income : Three months ended June 30, 2017 : 1,803 million yen ( 47.6% )

   Three months ended June 30, 2016 : 1,222 million yen ( 29.0% )

   Earnings per share	Diluted earnings per share
   Three months ended June 30, 2017 Three months ended June 30, 2016	Yen 49.30 32.12	Yen - -

   (Note) The Company conducted a two-for-one stock split of its common stock, with an effective date of December 1, 2016. Earnings per share are calculated by deeming stock splits to have occurred at the beginning of the previous consolidated fiscal year.

3. Consolidated financial position

4. Total assets		Net assets		Equity ratio
   As of June 30, 2017	Millions of	yen	Millions of	yen	%	54.4
   		39,487		21,492
   As of March 31, 2017		40,427		20,750		51.3

   (Reference) Shareholders' equity : Three months ended June 30, 2017 : 21,492 million yen

   Year ended March 31, 2017 : 20,750 million yen

5. Dividends

   Cash dividends per share
   1Q End	2Q End	3Q End	Year-End	Total
   Year ended March 2017 Year ending March 2018	Yen - -	Yen 0.00	Yen -	Yen 30.00	Yen 30.00
   Year ending March 2018 (forecast)	0.00	-	37.50	37.50

   (Notes) Revisions from the recent dividends forecast: None

6. Forecast of Consolidated Results for the Year Ending March 31, 2018 (from April 1, 2017 to March 31, 2018)

7. (Notes: % represents change from the previous year)

   Net sales	Operating income	Ordinary income	Net income	Earnings per share
   Second quarter-end (Cumulative)	Millions of yen %	Millions of yen %	Millions of yen %	Millions of yen %	Yen
   	19,608 9.7	3,897 14.0	3,959 15.9	2,725 14.9	73.25
   Year ending March 31, 2018	41,828 12.5	9,472 23.3	9,604 19.9	6,684 24.9	179.66

   (Note) Revisions from the recent earnings forecast: None

   * Notes

8. Changes in significant subsidiaries during the period : Yes Exclusion : 1 (JUNKEN MEDICAL Co., Ltd.)

9. Application of special accounting methods for the preparation of the consolidated quarterly financial statement

   : None

10. Changes in accounting policies, accounting estimates and restatement

    ( i ) Changes in accounting policies associated with revision of accounting standards : None (ii ) Changes in accounting policies other than ( i ) : None

11. Changes in accounting estimates : None

12. Restatement : None

13. Number of common shares issued (common stock)

    ( i ) Number of issued shares as of the period-end (including treasury stock): Three months ended June 30, 2017 : 45,209,988 shares

    Year ended March 31, 2017 : 45,209,988 shares (ii ) Number of treasury stock shares as of the period-end:

    Three months ended June 30, 2017 : 8,002,808 shares

    Year ended March 31, 2017 : 8,002,808 shares

14. Average number of common shares during the period (quarterly cumulative total): Three months ended June 30, 2017 : 37,207,180 shares

15. Three months ended June 30, 2016 : 37,207,180 shares

    (Note) The Company conducted a two-for-one stock split of its common stock, with an effective date of December 1, 2016.

    "(4) Number of common shares issued (common stock)" is calculated by deeming stock splits to have occurred at the beginning of the previous consolidated fiscal year.

    • This quarterly Summary Report is not subject to the quarterly audit.
    • Explanation regarding appropriate use of business forecasts, and other special instructions

    Any forward-looking statements in the report, including results forecasts, are based on information currently available to the Company and certain assumptions that the Company deems to be reasonable at the time this report was prepared. Actual results may differ significantly from the forecasts due to various factors.